DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care

Condition(s) studied

Investigational drug(s) / intervention(s)

GlucoTab: Insulin therapy will be started and adjusted according to the GlucoTab system with incorporated software algorithm. The goal of the basal-insulin algorithm is to maintain blood glucose within acceptable targets according to the predefined health status. For a limited time period after therapy start, three measurements per day are suggested by the algorithm to determine blood glucose. Insulin dosage titration will be performed according to the algorithm in GlucoTab under supervision of the nurses of the nursing homes/domiciliary nursing care. Correctional bolus insulin will be administered at defined time-points according to BG targets in the predefined health status. Nurses and nursing assistants will be trained in the use of the GlucoTab.

Diabetes Treatment: Diabetes Standard Care

Study summary

GlucoTab is a stand-alone software system to support healthcare professionals in the care of patients with diabetes mellitus or newly diagnosed hyperglycaemia who are treated with insulin and/or other glucose-lowering drugs or of patients only requiring glucose monitoring.

It provides a therapy algorithm for subcutaneous basal insulin therapy of patients with type 2 diabetes, which will be used in this study.

Eligibility

Primary outcome measure(s)

• Efficacy - mean percentage of fasting blood glucose in target range — ≥ 24 hours after start of the therapy by using the GlucoTab system
  Efficacy is assessed by evaluating the Mean percentage of Fasting Blood Glucose in the target range 80 - 180 mg/dl

Trial sites (1)

More Medical University of Graz trials in Spain

Other trials for the same condition